The RECOVERY trial team have won a National Institute of Health and Care Research (NIHR) Impact Prize in the “established investigator” category.
The Impact Prizes were launched this year to celebrate researchers and teams who have had a major impact on the health and wealth of the nation, as well as globally. Five prizes were awarded to research teams or individuals, and five to early-career researchers.
PSI Director Professor Sir Peter Horby, Moh Family Foundation Professor of Emerging Infectious Diseases and Joint Chief Investigator for the RECOVERY trial, said: “We recruited our first participants just over five years ago, on 19 March 2020, so this award is a timely reminder that research created the vaccines and treatments that were our saviour. Without it, we wouldn’t have been able to find out which treatments worked and which did not, saving hundreds of thousands if not millions of lives”.
“Continued investment in research is critical for ensuring we have the knowledge and tools ready for the next pandemic. RECOVERY is now testing treatments for flu and community acquired pneumonia but much more work is needed to make sure that the world is ready to respond at pace to future pandemic threats”.
Sir Martin Landray, Professor of Medicine and Epidemiology at Oxford Population Health, and Joint Chief Investigator for the RECOVERY trial, added: “We are honoured to receive this prize which recognises the contribution of everyone involved – the team at the Oxford Coordinating Centre, the hospital staff who worked tirelessly in the most exceptional circumstances, our funders and partners and, most importantly, the 50,000 trial participants.
Read the full story on the Nuffield Department of Population Health website.